Chemotherapy for malignant mesothelioma: From doxorubicin to vinorelbine
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1) , 62-69
- https://doi.org/10.1053/sonc.2002.30231
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Caelyx™ in malignant mesothelioma: A phase II EORTC studyAnnals of Oncology, 2000
- Evaluation of pleural diseases with FDG-PET imaging: preliminary reportThorax, 1997
- Weekly high-dose cisplatin in malignant pleural mesotheliomaAnnals of Oncology, 1994
- Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.American Journal of Roentgenology, 1992
- Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of Clinical Oncology, 1992
- Epirubicin in the Treatment of Malignant Mesothelioma: A Phase II Cooperative StudyTumori Journal, 1991
- A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group StudyInvestigational New Drugs, 1988
- A prospective study of detorubicin in malignant mesotheliomaCancer, 1985
- Malignant mesothelioma 1982: Review of 4710 published casesRespiratory Medicine, 1983
- Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experienceCancer, 1983